Avoro Capital Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $287M | Sell |
|
|||||
|
2023
Q3 | $290M | Buy |
|
|||||
|
2023
Q2 | $201M | Hold |
|
|||||
|
2023
Q1 | $207M | Hold |
|
|||||
|
2022
Q4 | $252M | Buy |
|
|||||
|
2022
Q3 | $388M | Hold |
|
|||||
|
2022
Q2 | $373M | Buy |
|
|||||
|
2022
Q1 | $438M | Buy |
|
|||||
|
2021
Q4 | $744M | Buy |
|
|||||
|
2021
Q3 | $885M | Hold |
|
|||||
|
2021
Q2 | $808M | Buy |
|
|||||
|
2021
Q1 | $801M | Buy |
|
|||||
|
2020
Q4 | $996M | Buy |
|
|||||
|
2020
Q3 | $721M | Buy |
|
|||||
|
2020
Q2 | $489M | Buy |
|
|||||
|
2020
Q1 | $316M | Buy |
|
|||||
|
2019
Q4 | $496M | Buy |
|
|||||
|
2019
Q3 | $292M | Sell |
|
|||||
|
2019
Q2 | $398M | Hold |
|
|||||
|
2019
Q1 | $283M | Sell |
|
|||||
|
2018
Q4 | $204M | Hold |
|
|||||
|
2018
Q3 | $226M | Hold |
|
|||||
|
2018
Q2 | $237M | Buy |
|
|||||
|
2018
Q1 | $135M | Hold |
|
|||||
|
2017
Q4 | $80.3M | Buy |
|
|||||
|
2017
Q3 | $43.4M | Buy |
|
|||||
|
2017
Q2 | $8.3M | Sell |
|
|||||
|
2017
Q1 | $12.4M | Buy |
|
|||||
|
2016
Q4 | $7.16M | Buy |
|
|||||
|
2016
Q3 | $9.84M | Buy |
|
|||||
|
2016
Q2 | $6.63M | Sell |
|
|||||
|
2016
Q1 | $30M | Buy |
|
|||||
|
2015
Q4 | $39.8M | Sell |
|
|||||
|
2015
Q3 | $50M | Buy |
|
|||||
|
2015
Q2 | $31.5M | Buy |
|
|||||
|
2015
Q1 | $9.41M | Buy |
|